Commonly used estimates of the genetic contribution to disease are subject to the same fallacies as bad luck estimates Jonas BjörkTomas AnderssonAnders Ahlbom ESSAY Open access 22 October 2019 Pages: 987 - 992
Repeated interviews are much better for drug exposure assessment than a single baseline interview Bruno H. Stricker COMMENTARY Open access 12 November 2019 Pages: 993 - 995
Statin use, hyperlipidemia, and risk of glioma David J. CoteBernard A. RosnerMeir J. Stampfer PHARMACO-EPIDEMIOLOGY 26 September 2019 Pages: 997 - 1011
A meta-analysis of cohort studies including dose-response relationship between shift work and the risk of diabetes mellitus Wenzhen LiZhenlong ChenZuxun Lu META-ANALYSIS 11 September 2019 Pages: 1013 - 1024
Do replicable profiles of multimorbidity exist? Systematic review and synthesis Ljoudmila BusijaKaren LimMarita P. McCabe REVIEW 17 October 2019 Pages: 1025 - 1053
Validated inference of smoking habits from blood with a finite DNA methylation marker set Silvana C. E. MaasAthina VidakiManfred Kayser METHODS Open access 07 September 2019 Pages: 1055 - 1074
A multi-state model based reanalysis of the Framingham Heart Study: Is dementia incidence really declining? Nadine BinderJames BalmfordMartin Schumacher NEURO-EPIDEMIOLOGY 14 October 2019 Pages: 1075 - 1083
Two-decade change in prevalence of cognitive impairment in the UK Connor RichardsonBlossom C. M. StephanCognitive Function and Ageing Study Collaboration NEURO-EPIDEMIOLOGY Open access 05 September 2019 Pages: 1085 - 1092
Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study Frida E. LundbergAnna L. V. JohanssonAnastasia N. Iliadou CANCER Open access 03 August 2019 Pages: 1093 - 1101
Interaction between co-morbidities and cancer survival Andrew G. RenehanNasra N. AlamMatthew Sperrin CORRESPONDENCE 24 August 2019 Pages: 1103 - 1105
